| 0 |
VACCINATION SITE ULCER |
1 |
0.1429 |
| 1 |
VACCINATION SITE VESICLES |
1 |
0.0455 |
| 2 |
VACCINATION SITE INDURATION |
1 |
0.0294 |
| 3 |
VACCINATION SITE PRURITUS |
1 |
0.0196 |
| 4 |
HUMAN ANTICHIMERIC ANTIBODY POSITIVE |
3 |
0.0089 |
| 5 |
BODY HEIGHT BELOW NORMAL |
3 |
0.0047 |
| 6 |
VACCINATION SITE ERYTHEMA |
1 |
0.0046 |
| 7 |
COOMBS POSITIVE HAEMOLYTIC ANAEMIA |
2 |
0.0044 |
| 8 |
PACKAGING DESIGN ISSUE |
1 |
0.0030 |
| 9 |
INJECTION SITE PUSTULE |
1 |
0.0026 |
| 10 |
BONE DENSITY INCREASED |
1 |
0.0025 |
| 11 |
DRY GANGRENE |
1 |
0.0016 |
| 12 |
ENTEROCOCCAL SEPSIS |
1 |
0.0012 |
| 13 |
JUVENILE IDIOPATHIC ARTHRITIS |
3 |
0.0012 |
| 14 |
ANTIBODY TEST POSITIVE |
2 |
0.0012 |
| 15 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
1 |
0.0011 |
| 16 |
PERIRECTAL ABSCESS |
1 |
0.0009 |
| 17 |
GRAFT VERSUS HOST DISEASE |
6 |
0.0008 |
| 18 |
LYMPHADENITIS |
2 |
0.0008 |
| 19 |
DRUG SPECIFIC ANTIBODY |
1 |
0.0007 |
| 20 |
SUPERINFECTION |
1 |
0.0007 |
| 21 |
INHIBITORY DRUG INTERACTION |
1 |
0.0006 |
| 22 |
PSEUDOMONAL SEPSIS |
1 |
0.0006 |
| 23 |
POLYARTHRITIS |
3 |
0.0006 |
| 24 |
CLOSTRIDIAL INFECTION |
1 |
0.0003 |
| 25 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
3 |
0.0003 |
| 26 |
HAEMOLYSIS |
2 |
0.0003 |
| 27 |
ADRENAL INSUFFICIENCY |
3 |
0.0002 |
| 28 |
LEG AMPUTATION |
1 |
0.0002 |
| 29 |
WHEELCHAIR USER |
1 |
0.0002 |
| 30 |
OBESITY |
3 |
0.0002 |
| 31 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 32 |
SYNOVITIS |
3 |
0.0002 |
| 33 |
PNEUMONIA ASPIRATION |
4 |
0.0002 |
| 34 |
JOINT EFFUSION |
1 |
0.0001 |
| 35 |
SEPTIC SHOCK |
6 |
0.0001 |
| 36 |
MALNUTRITION |
1 |
0.0001 |
| 37 |
COMA |
4 |
0.0001 |
| 38 |
C-REACTIVE PROTEIN INCREASED |
3 |
0.0001 |
| 39 |
CYTOPENIA |
1 |
0.0001 |
| 40 |
OFF LABEL USE |
68 |
0.0001 |
| 41 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 42 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
2 |
0.0001 |
| 43 |
PULMONARY MASS |
1 |
0.0001 |
| 44 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 45 |
BONE DENSITY DECREASED |
2 |
0.0001 |
| 46 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 47 |
IMPAIRED HEALING |
2 |
0.0001 |
| 48 |
DRUG LEVEL INCREASED |
1 |
0.0001 |
| 49 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 50 |
GASTROOESOPHAGEAL REFLUX DISEASE |
4 |
0.0000 |
| 51 |
JOINT INJURY |
1 |
0.0000 |
| 52 |
INFUSION RELATED REACTION |
3 |
0.0000 |
| 53 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
0.0000 |
| 54 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 55 |
ARTHRITIS |
3 |
0.0000 |
| 56 |
SKIN LESION |
1 |
0.0000 |
| 57 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 58 |
HEPATIC FAILURE |
1 |
0.0000 |
| 59 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 60 |
DRUG INTOLERANCE |
3 |
0.0000 |
| 61 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 62 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 63 |
MOBILITY DECREASED |
2 |
0.0000 |
| 64 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 65 |
PSORIASIS |
3 |
0.0000 |
| 66 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 67 |
MIGRAINE |
2 |
0.0000 |
| 68 |
LEUKOPENIA |
1 |
0.0000 |
| 69 |
SOMNOLENCE |
4 |
0.0000 |
| 70 |
ARTHROPATHY |
1 |
0.0000 |
| 71 |
PANCYTOPENIA |
1 |
0.0000 |
| 72 |
BONE PAIN |
1 |
0.0000 |
| 73 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 74 |
NEUTROPENIA |
2 |
0.0000 |
| 75 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 76 |
TREATMENT FAILURE |
1 |
0.0000 |
| 77 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 78 |
CONSTIPATION |
2 |
0.0000 |
| 79 |
SEPSIS |
1 |
0.0000 |
| 80 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 81 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 82 |
VOMITING |
3 |
0.0000 |
| 83 |
NAUSEA |
5 |
0.0000 |
| 84 |
DRUG INTERACTION |
1 |
0.0000 |
| 85 |
MYALGIA |
1 |
0.0000 |
| 86 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 87 |
DIARRHOEA |
3 |
0.0000 |
| 88 |
DRUG INEFFECTIVE |
6 |
0.0000 |
| 89 |
DECREASED APPETITE |
1 |
0.0000 |
| 90 |
DIZZINESS |
2 |
0.0000 |
| 91 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 92 |
PYREXIA |
1 |
0.0000 |
| 93 |
PRURITUS |
1 |
0.0000 |
| 94 |
HEADACHE |
1 |
0.0000 |
| 95 |
FATIGUE |
1 |
0.0000 |